Literature DB >> 26968469

A Tool to Assess Risk of De Novo Opioid Abuse or Dependence.

Thomas Ciesielski1, Reethi Iyengar2, Amit Bothra2, Dave Tomala2, Geoffrey Cislo3, Brian F Gage4.   

Abstract

BACKGROUND: Determining risk factors for opioid abuse or dependence will help clinicians practice informed prescribing and may help mitigate opioid abuse or dependence. The purpose of this study is to identify variables predicting opioid abuse or dependence.
METHODS: A retrospective cohort study using de-identified integrated pharmacy and medical claims was performed between October 2009 and September 2013. Patients with at least 1 opioid prescription claim during the index period (index claim) were identified. We ascertained risk factors using data from 12 months before the index claim (pre-period) and captured abuse or dependency diagnosis using data from 12 months after the index claim (postperiod). We included continuously eligible (pre- and postperiod) commercially insured patients aged 18 years or older. We excluded patients with cancer, residence in a long-term care facility, or a previous diagnosis of opioid abuse or dependence (identified by International Classification of Diseases 9th revision code or buprenorphine/naloxone claim in the pre-period). The outcome was a diagnosis of opioid abuse (International Classification of Diseases 9th revision code 304.0x) or dependence (305.5).
RESULTS: The final sample consisted of 694,851 patients. Opioid abuse or dependence was observed in 2067 patients (0.3%). Several factors predicted opioid abuse or dependence: younger age (per decade [older] odds ratio [OR], 0.68); being a chronic opioid user (OR, 4.39); history of mental illness (OR, 3.45); nonopioid substance abuse (OR, 2.82); alcohol abuse (OR, 2.37); high morphine equivalent dose per day user (OR, 1.98); tobacco use (OR, 1.80); obtaining opioids from multiple prescribers (OR, 1.71); residing in the South (OR, 1.65), West (OR, 1.49), or Midwest (OR, 1.24); using multiple pharmacies (OR, 1.59); male gender (OR, 1.43); and increased 30-day adjusted opioid prescriptions (OR, 1.05).
CONCLUSIONS: Readily available demographic, clinical, behavioral, pharmacy, and geographic information can be used to predict the likelihood of opioid abuse or dependence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Demographic factors; Opioid abuse; Opioid dependence; Pharmacy claims-based factors; Predictive model; Prescription drug monitoring program

Mesh:

Year:  2016        PMID: 26968469      PMCID: PMC5076552          DOI: 10.1016/j.amjmed.2016.02.014

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  25 in total

1.  The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd
Journal:  Drug Alcohol Depend       Date:  2006-04-18       Impact factor: 4.492

2.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

3.  Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.

Authors:  Nathaniel Katz; Lee Panas; Meelee Kim; Adele D Audet; Arnold Bilansky; John Eadie; Peter Kreiner; Florence C Paillard; Cindy Thomas; Grant Carrow
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-02       Impact factor: 2.890

Review 4.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

5.  American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

Authors:  Laxmaiah Manchikanti; Salahadin Abdi; Sairam Atluri; Carl C Balog; Ramsin M Benyamin; Mark V Boswell; Keith R Brown; Brian M Bruel; David A Bryce; Patricia A Burks; Allen W Burton; Aaron K Calodney; David L Caraway; Kimberly A Cash; Paul J Christo; Kim S Damron; Sukdeb Datta; Timothy R Deer; Sudhir Diwan; Ike Eriator; Frank J E Falco; Bert Fellows; Stephanie Geffert; Christopher G Gharibo; Scott E Glaser; Jay S Grider; Haroon Hameed; Mariam Hameed; Hans Hansen; Michael E Harned; Salim M Hayek; Standiford Helm; Joshua A Hirsch; Jeffrey W Janata; Alan D Kaye; Adam M Kaye; David S Kloth; Dhanalakshmi Koyyalagunta; Marion Lee; Yogesh Malla; Kavita N Manchikanti; Carla D McManus; Vidyasagar Pampati; Allan T Parr; Ramarao Pasupuleti; Vikram B Patel; Nalini Sehgal; Sanford M Silverman; Vijay Singh; Howard S Smith; Lee T Snook; Daneshvari R Solanki; Deborah H Tracy; Ricardo Vallejo; Bradley W Wargo
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

6.  A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS).

Authors:  Jennifer McNeely; Shiela M Strauss; Richard Saitz; Charles M Cleland; Joseph J Palamar; John Rotrosen; Marc N Gourevitch
Journal:  Am J Med       Date:  2015-03-10       Impact factor: 4.965

7.  Can we predict addiction to opioid analgesics? A possible tool to estimate the risk of opioid addiction in patients with pain.

Authors:  Katrin Skala; Lukas Reichl; Wilfried Ilias; Rudolf Likar; Gabriele Grogl-Aringer; Christina Wallner; Golda Schlaff; Peter Herrmann; Otto Lesch; Henriette Walter
Journal:  Pain Physician       Date:  2013 Nov-Dec       Impact factor: 4.965

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States.

Authors:  Carl L Roland; Ashish V Joshi; Jack Mardekian; Steven C Walden; James Harnett
Journal:  J Opioid Manag       Date:  2013 May-Jun

10.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

View more
  16 in total

1.  Short- and Long-term Opioid Use in Patients with Oral and Oropharynx Cancer.

Authors:  Jessica D McDermott; Megan Eguchi; William A Stokes; Arya Amini; Mohammad Hararah; Ding Ding; Allison Valentine; Cathy J Bradley; Sana D Karam
Journal:  Otolaryngol Head Neck Surg       Date:  2018-11-06       Impact factor: 3.497

2.  Dose and Duration of Opioid Use in Propensity Score-Matched, Privately Insured Opioid Users With and Without Spinal Cord Injury.

Authors:  Brittany N Hand; James S Krause; Kit N Simpson
Journal:  Arch Phys Med Rehabil       Date:  2018-01-04       Impact factor: 3.966

3.  Chronic Opioid Use Following Surgery for Oral Cavity Cancer.

Authors:  John Pang; Kathryn R Tringale; Viridiana J Tapia; William J Moss; Megan E May; Timothy Furnish; Linda Barnachea; Kevin T Brumund; Assuntina G Sacco; Robert A Weisman; Quyen T Nguyen; Jeffrey P Harris; Charles S Coffey; Joseph A Califano
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

4.  The Value of Shorter Initial Opioid Prescriptions: A Simulation Evaluation.

Authors:  Margrét V Bjarnadóttir; David R Anderson; Kislaya Prasad; Ritu Agarwal; D Alan Nelson
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

5.  Associations of Early Treatments for Low-Back Pain with Military Readiness Outcomes.

Authors:  Mary Jo Larson; Rachel Sayko Adams; Grant A Ritter; Andrea Linton; Thomas V Williams; Mayada Saadoun; Mark R Bauer
Journal:  J Altern Complement Med       Date:  2018-03-28       Impact factor: 2.579

6.  Empowering Post-Surgical Patients to Improve Opioid Disposal: A Before and After Quality Improvement Study.

Authors:  Jessica M Hasak; Carrie L Roth Bettlach; Katherine B Santosa; Ellen L Larson; Jean Stroud; Susan E Mackinnon
Journal:  J Am Coll Surg       Date:  2018-01-10       Impact factor: 6.113

7.  Predictors of long-term opioid use and opioid use disorder among construction workers: Analysis of claims data.

Authors:  Ann Marie Dale; Skye Buckner-Petty; Bradley A Evanoff; Brian F Gage
Journal:  Am J Ind Med       Date:  2020-11-24       Impact factor: 2.214

8.  Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.

Authors:  Pooja Lagisetty; Claire Garpestad; Angela Larkin; Colin Macleod; Derek Antoku; Stephanie Slat; Jennifer Thomas; Victoria Powell; Amy S B Bohnert; Lewei A Lin
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

9.  Patient Factors Associated With Opioid Consumption in the Month Following Major Surgery.

Authors:  Daniel B Larach; Michael J Sahara; Sawsan As-Sanie; Stephanie E Moser; Andrew G Urquhart; Jules Lin; Afton L Hassett; Joseph A Wakeford; Daniel J Clauw; Jennifer F Waljee; Chad M Brummett
Journal:  Ann Surg       Date:  2021-03-01       Impact factor: 13.787

10.  Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study.

Authors:  Gabriel A Brat; Denis Agniel; Andrew Beam; Brian Yorkgitis; Mark Bicket; Mark Homer; Kathe P Fox; Daniel B Knecht; Cheryl N McMahill-Walraven; Nathan Palmer; Isaac Kohane
Journal:  BMJ       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.